USDA Approved Required Statement to Owners and Veterinarians:
Possible Benefits of Experimental Autologous Prescription Product by CAVU
The benefit to your dog associated with this service is not completely known. This is an experimental and individualized therapeutic. Efficacy and safety have not been established. Due to its personalized nature, individual results will vary, and no individual result should be seen as typical. Results are not guaranteed.
Experimental Autologous Prescription Product by CAVU Possible Toxicities:
Fever, decreased energy, malaise, gastrointestinal upset (vomiting, diarrhea, loss of appetite), metallic smell to the breath, vasculitis, tachycardia, shock, off-target tissue destruction, cytokine release syndrome, tumor lysis syndrome, lymph node swelling, pulmonary edema, seizures, transfusion-like related side effects, anaphylaxis, aggravation of immune- mediated disease, "Grade 4 Immune Reaction", and death.